Skip to content
Screener

Pacific Biosciences of California PACB Q4 2025 Annual earnings

Reported February 12, 2026 · After market close

Revenue$44.6MBeat by $1.6M
EPS-$0.12Beat by $0.07
Revenue estimate$43.0M
EPS estimate-$0.19

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$43.8M
EPS estimate-$0.13

Financials

Q4 2025

Income statement

See full
Revenue$44.6M+13.8%
Gross profit$16.6M+64.7%
Operating income-$41.2M+73.1%
Net income-$40.4M—
EPS (diluted)-$0.13+70.5%

Balance sheet

See full
Cash & equivalents$65.3M+13.3%
Total debt$57.0M+129%
Total equity$5.3M-98.9%
Total assets$784.1M-37.8%

Cash flow

See full
Operating cash flow-$19.1M+37.8%
CapEx$861.0K-46.8%
Free cash flow-$19.9M+38.2%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$564.57M+4.8%
Enterprise value$556.35M+10.0%
P/S3.5×0.0×

Profitability

See full
Gross margin28.6%+4.4pp
Operating margin-346.2%+49.0pp
Net margin-341.5%+741pp
FCF margin-71.2%-23.2pp

Returns & leverage

See full
Return on equity-213.5%-314pp
Debt / equity10.7×+10.6×
Current ratio5.1×-2.3×

Segments

By geography

See full
Americas$20.7M+2.7%
Europe, Middle East and Africa$14.6M+44.5%
Asia-Pacific$9.3M+4.3%

By product

See full
Consumable revenue$21.6M+15.0%
Instrument revenue$17.3M+13.4%
Service and other revenue$5.7M+10.8%

By segment

See full
Reportable Segment$44.6M+13.8%

FAQ

When did Pacific Biosciences of California report Q4 2025 earnings?
Pacific Biosciences of California (PACB) reported Q4 2025 earnings on February 12, 2026 after market close.
What were Pacific Biosciences of California's Q4 2025 revenue and EPS?
Pacific Biosciences of California reported revenue of $44.6M and eps of $-0.12 for Q4 2025.
Did Pacific Biosciences of California beat estimates in Q4 2025?
Revenue beat the consensus estimate of $43.0M by $1.6M. EPS beat the consensus estimate of $-0.19 by $0.07.
How did Pacific Biosciences of California's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.8% from $39.2M a year earlier and eps grew 40.0% from $-0.20.
Where can I find Pacific Biosciences of California's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001299130-26-000017) and the 10-K periodic report (0001299130-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.